BROADCAST: Our Agency Services Are By Invitation Only. Apply Now To Get Invited!
ApplyRequestStart
Header Roadblock Ad
INVESTIGATIVE LIST
Preview

Date of Action: October 23, 2025
Entity: GlaxoSmithKline (GSK)
Drug: Belantamab mafodotin (Blenrep)
Advisory Committee: Oncologic Drugs Advisory Committee (ODAC)
Vote Count (July 2025): 7-1 Against (BPd regimen); 5-3 Against (BVd regimen)

The resurrection of Blenrep (belantamab mafodotin) in October 2025 stands as a defining case study in the FDA’s modern regulatory calculus, where statistical hazard ratios for efficacy are permitted to override profound safety signals and decisive advisory committee rejections. GSK successfully returned its BCMA-targeting antibody-drug conjugate (ADC) to the U.S. market three years after a humiliating withdrawal, securing a broad approval that blatantly contradicts the formal recommendation of the agency’s own external experts.

The full list continues behind the paywall.
Choose Your License
Same pricing for all paid lists
Monthly or Annual, pick what fits your team.
LicenseFeaturesMonthlyAnnual
Basic License
  • Single User License
  • Access 10 Paid Lists
  • 2 Ads in Newsletters
  • Next Business Day Email Support
$49
per month
Buy Monthly
$499
per year
Buy Annual
Premium License
  • 2 Users License
  • Access 50 Paid Lists per user
  • 1 Ad in Newsletters
  • Same Business Day Priority Email Support
$149
per month
Buy Monthly
$1,499
per year
Buy Annual
Enterprise License
  • 5 users license
  • Access Unlimited Paid lists per user
  • Zero Ads in Newsletters
  • Same Business Day Immediate Email Support
$199
per month
Buy Monthly
$1,999
per year
Buy Annual
This list is behind a paywall
Access requires a paid license and a logged in account.
Login to continue
Pinned News
Arctic LNG Project

Corruption in the Arctic LNG project expansion

Why it matters: The expansion of the Arctic LNG project in 2025 led to the creation of an illicit "shadow fleet" to bypass Western containment strategies. The geopolitical friction resulting…

Read Full Report
LATEST ARTICLES FROM OUR OUTLETS

Solar Grids or Scams? The Failure of Off-Grid Energy Startups

January 23, 2026 • Investigations, All, Business, Electricity, Energy, Markets, Startups, World

Why it matters: Investment frenzy in solar grids promised financial returns and social impact By 2025, sector faced a brutal correction with a collapse in…

Strikebreaking Firms: The quiet industry behind labor disputes

January 7, 2026 • Leaks, All, Labor

Why it matters: Strikebreaking firms have a controversial history in labor disputes, dating back to the late 19th century. The evolution of these firms from…

Corruption in Indian Cricket and League Teams: Ownership Exposed

October 11, 2025 • All, Corruption

Why it matters: Investigative reports and insider testimonies reveal deep-rooted financial malpractices in India's cricket leagues. Ownership corruption, shell companies, money laundering, and political influence…

Alarming Human Rights Abuses in Venezuelan Political Prison System

October 8, 2025 • All

Why it matters: Venezuela's ruling regimes have a history of political repression, with a sharp rise in political prisoners under Maduro. Human rights groups report…

RSS Hindutva and the “Bharat First” Ideology: An Investigative Profile

July 22, 2025 • All, Originals

Why it matters: The Rashtriya Swayamsevak Sangh (RSS) is India’s largest Hindu nationalist volunteer organization, with a controversial history rooted in Hindutva ideology. This investigation…

Windrush Reparations: Britain’s Long March Toward Overdue Justice

May 3, 2025 • All

Why it matters: Windrush generation's contributions: Caribbean migrants helped rebuild Britain after World War II, enriching various aspects of society. Windrush scandal: Decades later, many…